ARCHIVES

CTAC Discussion, Group Chairs Comment

This article is from The Cancer Letter archive.

Vol. 36 No. 46 | December 17, 2010

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

January 20, 2006

Conversation With The Cancer Letter: Seffrin To Retire After Restructuring ACS

January 24, 2014

Virus Program Report On Scientific Activities

August 15, 1975

CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs.

March 16, 2007

Bunn Says ASCO Is “Strong, Diverse, Respected, Growing”

June 6, 2003

Funding Opportunities: Komen Foundation Seeks Reviewers

February 28, 1997